Warning: The NCBI web site requires JavaScript to function. more...
Increased levels of active c-Src distinguish invasive from in situ lobular lesions.
Zou D, Yoon HS, Anjomshoaa A, Perez D, Fukuzawa R, Guilford P, Humar B.
Breast Cancer Res. 2009;11(4):R45. Epub 2009 Jul 7.
Related citations
Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B.
J Pathol. 2009 Jun;218(2):265-72.
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S.
Breast Cancer Res. 2009;11(4):R46. Epub 2009 Jul 9.
Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R, Zhuang Z, Merino MJ, Silverberg SG.
Hum Pathol. 1997 Mar;28(3):277-82.
Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
Giricz O, Reynolds PA, Ramnauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro N, Fineberg S, Kenny PA, Loudig O.
J Pathol. 2012 Jan;226(1):108-19. doi: 10.1002/path.2978. Epub 2011 Sep 26.
Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM, Silverman JF.
Am J Surg Pathol. 2005 Apr;29(4):534-43.
The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP, Shamonki J, Kinnaird M, Ray PS, Giuliano AE.
Ann Surg Oncol. 2011 Jul;18(7):1845-51. Epub 2011 Feb 2.
Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP.
Mod Pathol. 2002 Oct;15(10):1044-50.
Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C.
Radiology. 2004 Jun;231(3):813-9. Epub 2004 Apr 22.
Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast.
Mastracci TL, Shadeo A, Colby SM, Tuck AB, O'Malley FP, Bull SB, Lam WL, Andrulis IL.
Genes Chromosomes Cancer. 2006 Nov;45(11):1007-17.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
[Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S, Penzel R, Schirmacher P, Sinn HP.
Verh Dtsch Ges Pathol. 2007;91:208-13. German.
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL.
APMIS Suppl. 2003;(108):1-67. Review.
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP.
Breast Cancer Res Treat. 2008 Feb;107(3):331-5. Epub 2007 Mar 23.
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
Clin Cancer Res. 1999 May;5(5):1041-56.
The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR.
Breast Cancer Res. 2003;5(5):258-62. Epub 2003 Jul 29. Review.
Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA, Mrose HE, Ioffe OB.
Radiology. 2001 Feb;218(2):503-9.
Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA.
Clin Cancer Res. 2006 Jan 1;12(1):20-8.
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM.
Am J Clin Pathol. 2001 Apr;115(4):534-42.
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.
BMC Cancer. 2007 Mar 27;7:55.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on